| Company Name | Financial Report |
|---|---|
| Addressable Health, LLC | Year ended 31 Mar 2026 |
| BioPharma Communications LLC | Year ended 31 Mar 2026 |
| BioPharma Parent Holding, Inc. | Year ended 31 Mar 2026 |
| Cult Health LLC | Year ended 31 Mar 2026 |
| DT Associates Research and Consulting Services, Inc. | Year ended 31 Mar 2026 |
| DT Associates Research and Consulting Services Limited | Year ended 31 Mar 2026 |
| ILSL Holdings, Inc. | Year ended 31 Mar 2026 |
| Indegene Europe LLC, Switzerland | Year ended 31 Mar 2026 |
| Indegene Fareast Pte. Limited | Year ended 31 Mar 2026 |
| Indegene Healthcare Canada, Inc. | Year ended 31 Mar 2026 |
| Indegene Healthcare Germany GmbH | Year ended 31 Mar 2026 |
| Indegene Healthcare Mexico S DE RL DE CV | Year ended 31 Mar 2026 |
| Indegene Healthcare UK Limited | Year ended 31 Mar 2026 |
| Indegene Ireland Limited | Year ended 31 Mar 2026 |
| Indegene Japan Godo Kaisha | Year ended 31 Mar 2026 |
| Indegene Lifesystems Consulting (Shanghai) Co., Ltd | Year ended 31 Dec 2025 |
| Indegene Spain S.L.U | Year ended 31 Mar 2026 |
| Indegene, Inc. | Year ended 31 Mar 2026 |
| MJL Advertising Limited | Year ended 31 Mar 2026 |
| MJL Communications Group Limited | Year ended 31 Mar 2026 |
| Trilogy Writing and Consulting GmbH | Year ended 31 Mar 2026 |
| Trilogy Writing and Consulting, Inc. (US) | Year ended 31 Mar 2026 |
| Trilogy Writing and Consulting Limited (UK) | Year ended 31 Mar 2026 |
| Warn and Co Limited | Year ended 31 Mar 2026 |
The Company acquired Cake Kommunikations Holdings GmbH, Cake Kommunikations GmbH (AT), CAKE Kommunikations GmbH (DE), and CAKE Kommunikations AG (Switzerland) on 30 January 2026. While Cake Kommunikations Holdings GmbH and Cake Kommunikations GmbH (AT) follow a financial year from 1 April to 31 March, CAKE Kommunikations GmbH (DE) and CAKE Kommunikations AG (Switzerland) follow a financial year from 1 January to 31 December. Therefore, the Company does not have audited or unaudited financial statements of these entities for the year ended 31 March 2026.
| Company Name | Financial Report |
|---|---|
| Cult Health, LLC | Year ended 31 Mar 2025 |
| DT Associates Research and Consulting, Inc. | Year ended 31 Mar 2025 |
| DT Associates Research and Consulting Services Ltd | Year ended 31 Mar 2025 |
| ILSL Holdings, Inc. | Year ended 31 Mar 2025 |
| Indegene Europe LLC | Year ended 31 Mar 2025 |
| Indegene Fareast Pte, Ltd. | Year ended 31 Mar 2025 |
| Indegene Healthcare Germany GmbH | Year ended 31 Mar 2025 |
| Indegene Healthcare Mexico S DE RL DE CV | Year ended 31 Mar 2025 |
| Indegene Healthcare UK Limited | Year ended 31 Mar 2025 |
| Indegene Ireland Limited | Year ended 31 Mar 2025 |
| Indegene Japan, LLC | Year ended 31 Mar 2025 |
| Indegene Lifesystems Consulting (Shanghai) Co. Ltd. | Year ended 31 Dec 2024 |
| Indegene Spain S.L | Year ended 31 Mar 2025 |
| Indegene, Inc. | Year ended 31 Mar 2025 |
| Services Indegene Aptilon, Inc. | Year ended 31 Mar 2025 |
| Trilogy Writing & Consulting GmbH | Year ended 31 Mar 2025 |
| Trilogy Writing & Consulting, Inc | Year ended 31 Mar 2025 |
| Trilogy Writing & Consulting Limited | 15 months period ended 31 Mar 2025 |
| Trilogy Writing & Consulting ULC | Year ended 31 Mar 2025 |
The Company acquired MJL Communications Group Ltd and MJL Advertising Limited on 25 March 2025. However, their financial year is from 1 January to 31 December. Therefore, the Company does not have any audited / unaudited financial statements for the year ended 31 March 2025.
| Company Name | Financial Report |
|---|---|
| Cult Health, LLC | AR - FR 2023 - 2024 |
| DT Associates Research and Consulting, Inc, | AR - FR 2023 - 2024 |
| DT Associates Research and Consulting Services Ltd | AR - FR 2023 - 2024 |
| ILSL Holdings, Inc. | AR - FR 2023 - 2024 |
| Indegene Europe LLC | AR - FR 2023 - 2024 |
| Indegene Fareast Pte, Ltd. | AR - FR 2023 - 2024 |
| Indegene Healthcare Germany GmbH | AR - FR 2023 – 2024 |
| Indegene Healthcare Mexico S DE RL DE CV | AR - FR 2023 - 2024 |
| Indegene Healthcare UK Limited | AR - FR 2023 - 2024 |
| Indegene, Inc. | AR - FR 2023 – 2024 |
| Indegene Ireland Limited | AR - FR 2023 – 2024 |
| Indegene Japan, LLC | AR - FR 2023 – 2024 |
| Indegene Lifesystems Consulting (Shanghai) Co. Ltd. | AR - FR 2023 – 2024 |
| Services Indegene Aptilon, Inc. | AR - FR 2023 – 2024 |
The Company acquired Trilogy Writing & Consulting GmbH, Trilogy Writing & Consulting, Inc.Trilogy Writing & Consulting Limited and Trilogy Writing & Consulting ULC on 22 March 2024. However, their financial year is from 1 January to 31 December. Therefore, the Company does not have any audited / unaudited financial statements for the year ended 31 March 2024.
| Company Name | Financial Report |
|---|---|
| ILSL Holdings, Inc. | Audited Financials FY22-23 |
| ILSL Holdings, Inc. | Audited Financials FY2021-22, FY2020-21 and FY2019-20 |
| Indegene, Inc. | Audited Financials FY2022-23 |
| Indegene, Inc. | Audited Financials FY2021-22, FY2020-21 and FY2019-20 |